Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Phenoxypyridine inhibitors of Na+/Ca2+ exchange from Taisho

April 19, 1999

HMR continues to focus R&D resources in the area of Na+/H+ exchange inhibitors

April 14, 1999

Tularik presents novel compounds with dual antiproliferative and hypolipidemic effects

April 9, 1999

E-047/1 more effective than known antiarrhythmics against ventricular fibrillation

April 8, 1999

Novel inotropic agents from Prassis-Sigma-Tau compare favorably with digoxin in animal models

April 8, 1999

MCC-135 improves LV function and prolongs survival in hamster model of cardiomyopathy

April 8, 1999

New orally active NEP inhibitor exerts beneficial effects in rabbit model of CHF

April 7, 1999

LBP199-IgG1 Fc: a new endotoxin-neutralizing fusion protein

April 7, 1999

Zeneca files sNDA for change in dosing for Zestril

April 6, 1999

Tasosartan provides effective control of essential hypertension in 10-week study

April 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...